Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, August 18, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8899 POSTS
0 Comments
https://bostonlifesciencestimes.com
Biotech
Hypertrophic Cardiomyopathy Market Reached $3.2 Billion in 2025, DelveInsight Says
Life Sciences Times
-
August 17, 2026
0
Technology
OmniAb, Eli Lilly Sign Ion Channel Discovery Deal Worth Up to $370 Million
Life Sciences Times
-
August 17, 2026
0
Biotech
SINOVAC First-Half Sales Rise 12.9% as Overseas Revenue Jumps 82%
Life Sciences Times
-
August 17, 2026
0
People on the Move
Juvena Therapeutics Names Julie Anne Smith CEO as JUV-161 Advances in Phase 2
Life Sciences Times
-
August 17, 2026
0
Life Sciences
ENDRA Life Sciences Reports $160,000 Profit, Plans Noble Africa Merger
Life Sciences Times
-
August 17, 2026
0
Biotech
Zai Lab, argenx Report Positive Phase 3 Results for Efgartigimod in Autoimmune Myositis
Life Sciences Times
-
August 17, 2026
0
Pharma
ENHERTU Improves Progression-Free Survival in First-Line HER2-Mutant Lung Cancer Trial
Life Sciences Times
-
August 17, 2026
0
Biotech
Insilico Medicine Launches Virtual Aging Cell Platform for AI-Driven Drug Discovery
Life Sciences Times
-
August 14, 2026
0
Public Health
Shatterproof Backs Massachusetts Restrictions on Kratom Products
Life Sciences Times
-
August 14, 2026
0
Life Sciences
Whitehead Institute Researchers Find Polyamines Help Protect Cells From Iron Overload
Life Sciences Times
-
August 14, 2026
0
1
2
3
...
890
Page 2 of 890
TOP AUTHORS
Life Sciences Times
8899 POSTS
0 Comments
https://bostonlifesciencestimes.com
Most Read
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
August 18, 2026
Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer
August 18, 2026
Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline
August 18, 2026
Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs
August 18, 2026